Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection:
about
Clinical applications of palifermin: amelioration of oral mucositis and other potential indicationsOptimizing current and emerging therapies in multiple myeloma: a guide for the hematologist.A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function.Palifermin and Chlorhexidine Mouthwashes in Prevention of Chemotherapy-Induced Mucositis in Children with Acute Lymphocytic Leukemia: a Randomized Controlled Trial.Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
P2860
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection:
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melphalan 180 mg/m2 can be saf ...... palifermin for cytoprotection:
@en
Melphalan 180 mg/m2 can be saf ...... gous stem cell transplantation
@nl
type
label
Melphalan 180 mg/m2 can be saf ...... palifermin for cytoprotection:
@en
Melphalan 180 mg/m2 can be saf ...... gous stem cell transplantation
@nl
prefLabel
Melphalan 180 mg/m2 can be saf ...... palifermin for cytoprotection:
@en
Melphalan 180 mg/m2 can be saf ...... gous stem cell transplantation
@nl
P2093
P2860
P1476
Melphalan 180 mg/m2 can be saf ...... on: results of a phase I trial
@en
P2093
Abhinav Deol
Jeffrey Zonder
Joseph Uberti
Judith Abrams
Lawrence Lum
Lois Ayash
Marie Ventimiglia
Rishi Agarwal
Simon Cronin
Voravit Ratanatharathorn
P2860
P304
P356
10.1016/J.BBMT.2012.03.010
P577
2012-03-24T00:00:00Z